Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Significance of Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients With Metastatic Gastric or Gastroesophageal Junction Cancer Administered Trifluridine/Tipiracil.
Hashimoto I, Kano K, Onuma S, Suematsu H, Nagasawa S, Kanematsu K, Furusawa K, Hamaguchi T, Watanabe M, Hayashi K, Furuta M, Inokuchi Y, Machida N, Aoyama T, Yamada T, Rino Y, Ogata T, Oshima T. Hashimoto I, et al. Among authors: onuma s. Anticancer Res. 2023 Apr;43(4):1689-1697. doi: 10.21873/anticanres.16321. Anticancer Res. 2023. PMID: 36974783
The Clinical Impact of Synchronous and Metachronous Other Primary Cancer in Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T, Ju M, Komori K, Tamagawa H, Tamagawa A, Maezawa Y, Hashimoto I, Kano K, Hara K, Cho H, Morita J, Segami K, Onodera A, Endo K, Onuma S, Oshima T, Yukawa N, Rino Y. Aoyama T, et al. Among authors: onuma s. In Vivo. 2022 Sep-Oct;36(5):2514-2520. doi: 10.21873/invivo.12987. In Vivo. 2022. PMID: 36099136 Free PMC article.
Evaluating prognostic significance of preoperative C-reactive protein to albumin ratio in older patients with pathological stage II or III colorectal cancer.
Numata K, Ono Y, Ju M, Onuma S, Tanaka A, Kawabe T, Sawazaki S, Higuchi A, Yamanaka K, Hatori S, Saeki H, Matsukawa H, Rino Y, Tani K. Numata K, et al. Among authors: onuma s. Ann Coloproctol. 2024 Apr;40(2):161-168. doi: 10.3393/ac.2022.00367.0052. Epub 2022 Oct 11. Ann Coloproctol. 2024. PMID: 36217812 Free PMC article.
Evaluation of Irinotecan and Trifluridine/Tipiracil as Fourth-line Treatments After Third-line Nivolumab for Advanced Gastric Cancer.
Hayashi K, Furuta M, Furusawa K, Hamaguchi T, Watanabe M, Inokuchi Y, Onuma S, Hashimoto I, Suematsu H, Nagasawa S, Kanematsu K, Yamada T, Notsu A, Ogata T, Oshima T, Machida N, Furuse J, Maeda S. Hayashi K, et al. Among authors: onuma s. Anticancer Res. 2023 Jun;43(6):2831-2840. doi: 10.21873/anticanres.16452. Anticancer Res. 2023. PMID: 37247885
Clinical Effect of the C-Reactive Protein to Serum Albumin Ratio in Patients with Metastatic Gastric or Gastroesophageal Junction Cancer Treated with Trifluridine/Tipiracil.
Hashimoto I, Kano K, Onuma S, Suematsu H, Nagasawa S, Kanematsu K, Furusawa K, Hamaguchi T, Watanabe M, Hayashi K, Furuta M, Inokuchi Y, Machida N, Aoyama T, Yamada T, Rino Y, Ogata T, Oshima T. Hashimoto I, et al. Among authors: onuma s. J Pers Med. 2023 May 31;13(6):923. doi: 10.3390/jpm13060923. J Pers Med. 2023. PMID: 37373912 Free PMC article.
Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal Cancer.
Tamagawa H, Tamagawa A, Aoyama T, Hashimoto I, Maezawa Y, Hara K, Kato A, Kamiya N, Otani K, Numata M, Kazama K, Morita J, Tanabe M, Onuma S, Cho H, Sawazaki S, Ohshima T, Yukawa N, Mitsudo K, Saito A, Rino Y. Tamagawa H, et al. Among authors: onuma s. In Vivo. 2023 Sep-Oct;37(5):2253-2259. doi: 10.21873/invivo.13327. In Vivo. 2023. PMID: 37652503 Free PMC article.
96 results